Percutaneous Catheter Ablation of Atrial Fibrillation in Patients with Post-Atrial Septal Defect Device Closure & Operation

Jongil Choi, Yae Min Park, Ji Eun Ban, Dae In Lee, Jun Hyuk Kang, Hyung Don Kook, Hwan Cheol Park, Ji Hwan Park, Seung Yong Shin, Hong Euy Lim, Sang Weon Park, Young Hoon Kim

Research output: Contribution to journalArticle

Abstract

Background: Transseptal puncture (TSP) and left atrial (LA) ablation is perceived to be difficult in patients with closure of atrial septal defect (ASD). We described our experience with catheter ablation of AF via TSP in patients with repaired ASD. Methods: Among 8 patients with repaired ASD, 6 patients underwent surgical repair (patch 5: pericardium 2, Dacron 2, Gore-Tex 1; suture closure 1) and Amplatzer occluder was used in 2 patients. Results: Double TSP followed by LA catheter ablation was performed in all patients 14 ± 11 years after ASD closure. Atrial tachycardia (AT) was documented/induced in 7 patients, in whom carvo-tricuspid isthmus was ablated. AT was terminated in 4 patients during ablation nearby closure device/material (1 right PV; 1 posterior wall of right atrium; 2 right septum). In 7 patients, there was no inducible AF/AT after ablation. There was no complication. During mean 18-month, there was no recurrence of AF/AT after procedure. No evidence of iatrogenic shunt flow was shown at the TSP site in 3 patients with echocardiographic follow-up after median 6 months. Conclusion: Percutaneous catheter ablation via TSP is feasible and safe in patients with repaired ASD and has a good long-term outcome. The ASD closure device/matrial can be a part of the substrate of coexisted AT.

Original languageEnglish
JournalJournal of Arrhythmia
Volume27
DOIs
Publication statusPublished - 2011 Jan 1

Fingerprint

Catheter Ablation
Atrial Heart Septal Defects
Atrial Fibrillation
Equipment and Supplies
Punctures
Tachycardia
Septal Occluder Device
Polyethylene Terephthalates
Pericardium
Heart Atria
Sutures

Keywords

  • atrial fibrillation
  • atrial septal defect closure
  • catheter ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous Catheter Ablation of Atrial Fibrillation in Patients with Post-Atrial Septal Defect Device Closure & Operation. / Choi, Jongil; Park, Yae Min; Ban, Ji Eun; Lee, Dae In; Kang, Jun Hyuk; Kook, Hyung Don; Park, Hwan Cheol; Park, Ji Hwan; Shin, Seung Yong; Lim, Hong Euy; Park, Sang Weon; Kim, Young Hoon.

In: Journal of Arrhythmia, Vol. 27, 01.01.2011.

Research output: Contribution to journalArticle

Choi, Jongil ; Park, Yae Min ; Ban, Ji Eun ; Lee, Dae In ; Kang, Jun Hyuk ; Kook, Hyung Don ; Park, Hwan Cheol ; Park, Ji Hwan ; Shin, Seung Yong ; Lim, Hong Euy ; Park, Sang Weon ; Kim, Young Hoon. / Percutaneous Catheter Ablation of Atrial Fibrillation in Patients with Post-Atrial Septal Defect Device Closure & Operation. In: Journal of Arrhythmia. 2011 ; Vol. 27.
@article{a841237468ad44b589a996fea38d0b49,
title = "Percutaneous Catheter Ablation of Atrial Fibrillation in Patients with Post-Atrial Septal Defect Device Closure & Operation",
abstract = "Background: Transseptal puncture (TSP) and left atrial (LA) ablation is perceived to be difficult in patients with closure of atrial septal defect (ASD). We described our experience with catheter ablation of AF via TSP in patients with repaired ASD. Methods: Among 8 patients with repaired ASD, 6 patients underwent surgical repair (patch 5: pericardium 2, Dacron 2, Gore-Tex 1; suture closure 1) and Amplatzer occluder was used in 2 patients. Results: Double TSP followed by LA catheter ablation was performed in all patients 14 ± 11 years after ASD closure. Atrial tachycardia (AT) was documented/induced in 7 patients, in whom carvo-tricuspid isthmus was ablated. AT was terminated in 4 patients during ablation nearby closure device/material (1 right PV; 1 posterior wall of right atrium; 2 right septum). In 7 patients, there was no inducible AF/AT after ablation. There was no complication. During mean 18-month, there was no recurrence of AF/AT after procedure. No evidence of iatrogenic shunt flow was shown at the TSP site in 3 patients with echocardiographic follow-up after median 6 months. Conclusion: Percutaneous catheter ablation via TSP is feasible and safe in patients with repaired ASD and has a good long-term outcome. The ASD closure device/matrial can be a part of the substrate of coexisted AT.",
keywords = "atrial fibrillation, atrial septal defect closure, catheter ablation",
author = "Jongil Choi and Park, {Yae Min} and Ban, {Ji Eun} and Lee, {Dae In} and Kang, {Jun Hyuk} and Kook, {Hyung Don} and Park, {Hwan Cheol} and Park, {Ji Hwan} and Shin, {Seung Yong} and Lim, {Hong Euy} and Park, {Sang Weon} and Kim, {Young Hoon}",
year = "2011",
month = "1",
day = "1",
doi = "10.4020/jhrs.27.PE4_104",
language = "English",
volume = "27",
journal = "Journal of Arrhythmia",
issn = "1880-4276",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Percutaneous Catheter Ablation of Atrial Fibrillation in Patients with Post-Atrial Septal Defect Device Closure & Operation

AU - Choi, Jongil

AU - Park, Yae Min

AU - Ban, Ji Eun

AU - Lee, Dae In

AU - Kang, Jun Hyuk

AU - Kook, Hyung Don

AU - Park, Hwan Cheol

AU - Park, Ji Hwan

AU - Shin, Seung Yong

AU - Lim, Hong Euy

AU - Park, Sang Weon

AU - Kim, Young Hoon

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Background: Transseptal puncture (TSP) and left atrial (LA) ablation is perceived to be difficult in patients with closure of atrial septal defect (ASD). We described our experience with catheter ablation of AF via TSP in patients with repaired ASD. Methods: Among 8 patients with repaired ASD, 6 patients underwent surgical repair (patch 5: pericardium 2, Dacron 2, Gore-Tex 1; suture closure 1) and Amplatzer occluder was used in 2 patients. Results: Double TSP followed by LA catheter ablation was performed in all patients 14 ± 11 years after ASD closure. Atrial tachycardia (AT) was documented/induced in 7 patients, in whom carvo-tricuspid isthmus was ablated. AT was terminated in 4 patients during ablation nearby closure device/material (1 right PV; 1 posterior wall of right atrium; 2 right septum). In 7 patients, there was no inducible AF/AT after ablation. There was no complication. During mean 18-month, there was no recurrence of AF/AT after procedure. No evidence of iatrogenic shunt flow was shown at the TSP site in 3 patients with echocardiographic follow-up after median 6 months. Conclusion: Percutaneous catheter ablation via TSP is feasible and safe in patients with repaired ASD and has a good long-term outcome. The ASD closure device/matrial can be a part of the substrate of coexisted AT.

AB - Background: Transseptal puncture (TSP) and left atrial (LA) ablation is perceived to be difficult in patients with closure of atrial septal defect (ASD). We described our experience with catheter ablation of AF via TSP in patients with repaired ASD. Methods: Among 8 patients with repaired ASD, 6 patients underwent surgical repair (patch 5: pericardium 2, Dacron 2, Gore-Tex 1; suture closure 1) and Amplatzer occluder was used in 2 patients. Results: Double TSP followed by LA catheter ablation was performed in all patients 14 ± 11 years after ASD closure. Atrial tachycardia (AT) was documented/induced in 7 patients, in whom carvo-tricuspid isthmus was ablated. AT was terminated in 4 patients during ablation nearby closure device/material (1 right PV; 1 posterior wall of right atrium; 2 right septum). In 7 patients, there was no inducible AF/AT after ablation. There was no complication. During mean 18-month, there was no recurrence of AF/AT after procedure. No evidence of iatrogenic shunt flow was shown at the TSP site in 3 patients with echocardiographic follow-up after median 6 months. Conclusion: Percutaneous catheter ablation via TSP is feasible and safe in patients with repaired ASD and has a good long-term outcome. The ASD closure device/matrial can be a part of the substrate of coexisted AT.

KW - atrial fibrillation

KW - atrial septal defect closure

KW - catheter ablation

UR - http://www.scopus.com/inward/record.url?scp=85009591352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009591352&partnerID=8YFLogxK

U2 - 10.4020/jhrs.27.PE4_104

DO - 10.4020/jhrs.27.PE4_104

M3 - Article

AN - SCOPUS:85009591352

VL - 27

JO - Journal of Arrhythmia

JF - Journal of Arrhythmia

SN - 1880-4276

ER -